Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Classifica tra le azioni #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Prezzo delle azioni
$71.40
Capitalizzazione di mercato
$29.93B
Variazione (1 giorno)
-0.13%
Variazione (1 anno)
-51.06%
Paese
US
Scambia Zoetis Inc. (ZTS)

Categoria

Margine operativo per Zoetis Inc. (ZTS)
Margine operativo al September 2026 TTM: 37.00%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Zoetis Inc., il margine operativo attuale (TTM) è 37.00%. Alla fine del 2023, il margine operativo era 35.92%.
Storico del margine operativo per Zoetis Inc. da 2009 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) 37.00% 0.95%
2024 36.65% 2.03%
2023 35.92% -0.88%
2022 36.24% 0.53%
2021 36.05% 6.06%
2020 33.99% 5.43%
2019 32.24% -0.15%
2018 32.29% -0.77%
2017 32.54% 13.30%
2016 28.72% 26.46%
2015 22.71% 12.04%
2014 20.27% 12.61%
2013 18.00% -8.63%
2012 19.70% 21.91%
2011 16.16% 87.25%
2010 8.63% -15.23%
2009 10.18% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
43.92% -98.81%
US
26.81% -99.28%
US
29.32% -99.21%
US
26.59% -99.28%
CH
16.65% -99.55%
US
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.